TREM2 and Alzheimer disease: Signaling pathways involved in metabolic reprogramming, specifically in the glycolytic shift, include the involvement of PFKB3, mTOR, TREM2, and HIF‐1α genes, which have all been implicated in impaired microglia metabolic reprogramming in AD [19, 48, 49].